PL3240529T3 - Stabilne kompozycje farmaceutyczne zawierające mykafunginę - Google Patents

Stabilne kompozycje farmaceutyczne zawierające mykafunginę

Info

Publication number
PL3240529T3
PL3240529T3 PL15817912T PL15817912T PL3240529T3 PL 3240529 T3 PL3240529 T3 PL 3240529T3 PL 15817912 T PL15817912 T PL 15817912T PL 15817912 T PL15817912 T PL 15817912T PL 3240529 T3 PL3240529 T3 PL 3240529T3
Authority
PL
Poland
Prior art keywords
micafungin
pharmaceutical compositions
stable pharmaceutical
stable
compositions
Prior art date
Application number
PL15817912T
Other languages
English (en)
Inventor
Sergio Arroyo Hidalgo
Original Assignee
Galenicum Health S.L.U.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=52134071&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL3240529(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Galenicum Health S.L.U. filed Critical Galenicum Health S.L.U.
Publication of PL3240529T3 publication Critical patent/PL3240529T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
PL15817912T 2014-12-31 2015-12-30 Stabilne kompozycje farmaceutyczne zawierające mykafunginę PL3240529T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP14200697 2014-12-31
EP15817912.7A EP3240529B1 (en) 2014-12-31 2015-12-30 Stable pharmaceutical compositions comprising micafungin
PCT/EP2015/081384 WO2016107890A1 (en) 2014-12-31 2015-12-30 Stable pharmaceutical compositions comprising micafungin

Publications (1)

Publication Number Publication Date
PL3240529T3 true PL3240529T3 (pl) 2022-05-02

Family

ID=52134071

Family Applications (1)

Application Number Title Priority Date Filing Date
PL15817912T PL3240529T3 (pl) 2014-12-31 2015-12-30 Stabilne kompozycje farmaceutyczne zawierające mykafunginę

Country Status (5)

Country Link
EP (1) EP3240529B1 (pl)
DK (1) DK3240529T3 (pl)
ES (1) ES2777942T3 (pl)
PL (1) PL3240529T3 (pl)
WO (1) WO2016107890A1 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI3554474T3 (fi) * 2016-12-16 2024-02-21 Baxter Int Mikafungiinikoostumuksia
US20220040092A1 (en) * 2020-06-27 2022-02-10 RK Pharma Solutions LLC Ready to use injectable formulations of Micafungin Sodium

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI233805B (en) 1999-07-01 2005-06-11 Fujisawa Pharmaceutical Co Stabilized pharmaceutical composition in lyophilized form as antifungal agent
JP2006069929A (ja) 2004-08-31 2006-03-16 Konica Minolta Medical & Graphic Inc 真菌症治療製剤およびその製造方法
CN102614491B (zh) * 2011-01-31 2014-04-16 上海天伟生物制药有限公司 一种含有棘白菌素类抗真菌剂米卡芬净的药用组合物及其制备方法和用途

Also Published As

Publication number Publication date
WO2016107890A1 (en) 2016-07-07
EP3240529A1 (en) 2017-11-08
EP3240529B1 (en) 2022-02-02
DK3240529T3 (da) 2022-02-28
ES2777942T1 (es) 2020-08-06
ES2777942T3 (es) 2022-04-22

Similar Documents

Publication Publication Date Title
HK1245071A1 (zh) 用於回腸-空腸給藥的組合物
HK1225655A1 (zh) 包含azd9291的藥用組合物
GB201419257D0 (en) Pharmaceutical compositions
GB201618482D0 (en) Pharmaceutical compositions
GB201409471D0 (en) Pharmaceutical composition
IL249553A0 (en) Pharmaceutical preparations
GB201409488D0 (en) Pharmaceutical composition
ZA201702086B (en) Long acting pharmaceutical compositions
GB201409485D0 (en) Pharmaceutical composition
HK1245073A1 (zh) 藥物組合物
ZA201502073B (en) Pharmaceutical composition
IL250817A0 (en) pharmaceutical preparations
ZA201508726B (en) Pharmaceutical composition
PL3240529T3 (pl) Stabilne kompozycje farmaceutyczne zawierające mykafunginę
PL3200772T3 (pl) Kompozycje farmaceutyczne zawierające alpelisyb
PL3089740T3 (pl) Kompozycja farmaceutyczna
GB201417589D0 (en) Pharmaceutical Formulations
SG10201504332VA (en) Pharmaceutical Composition
PT3319596T (pt) Composições farmacêuticas
GB201506598D0 (en) Pharmaceutical compositions
SG2014014872A (en) Pharmaceutical compositions
GB201408432D0 (en) Pharmaceutical compositions